טוען...

Inhibition of Notch Signaling in Combination with Paclitaxel Reduces Platinum-Resistant Ovarian Tumor Growth

Introduction: Ovarian cancer (OvCa) is the most lethal gynecologic malignancy in the United States because of chemoresistant recurrent disease. Our objective was to investigate the efficacy of inhibiting the Notch pathway with a γ-secretase inhibitor (GSI) in an OvCa patient-derived xenograft model...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Groeneweg, Jolijn W., DiGloria, Celeste M., Yuan, Jing, Richardson, William S., Growdon, Whitfield B., Sathyanarayanan, Sriram, Foster, Rosemary, Rueda, Bo R.
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2014
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4083224/
https://ncbi.nlm.nih.gov/pubmed/25072022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2014.00171
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!